Concepedia

The effect of MCI-9042 on serotonin-induced platelet aggregation in type 2 diabetes mellitus

M.H. Pietraszek, Yumiko Takada, A Taminato, Tatsuya Yoshimi, Ikuo Watanabe, Akikazu Takada

Thrombosis Research · 1993 · 23 citations · 14 references

DOI

Concepts

References

14

Increased platelet thromboxane synthesis in diabetes mellitus.

Perry V. Halushka, Richard C. Rogers, C B Loadholt et al. · PubMed · 1981 · 257 citations

, , +11

Serotonin and the Cardiovascular System

Edward D. Fröhlich · Mayo Clinic Proceedings · 1985 · 256 citations

, , +12

Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist

Fred De Clerck, Jean‐Louis David, Paul A. J. Janssen · Inflammation Research · 1982 · 166 citations

, , +16

MCI–9042, a New Antiplatelet Agent Is a Selective S2-Serotonergic Receptor Antagonist

Hiroto Hara, Masanori Osakabe, A Kitajima et al. · Thrombosis and Haemostasis · 1991 · 121 citations

, , +17

5‐Hydroxytryptamine in Peripheral Reactions

Robin Hoult · FEBS Letters · 1983 · 114 citations · Full text

, , +4